{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:00:07Z","timestamp":1762506007054},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1097\/dad.0b013e3181c036de","type":"journal-article","created":{"date-parts":[[2012,11,20]],"date-time":"2012-11-20T08:47:01Z","timestamp":1353401221000},"page":"e119-e124","source":"Crossref","is-referenced-by-count":23,"title":["Atypical Hydroa Vacciniforme-Like Epstein-Barr Virus Associated T\/NK-Cell Lymphoproliferative Disorder"],"prefix":"10.1097","volume":"34","author":[{"given":"Hye Young","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin Ok","family":"Baek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jong Rok","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang Hui","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"In Sang","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joo Young","family":"Roh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-21-20210202","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1086\/428097","article-title":". Long term shedding of infectious Epstein-Barr virus after infectious mononucleosis.","volume":"191","author":"Fafi-Kremer","year":"2005","journal-title":"J Infect Dis"},{"key":"R2-21-20210202","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3346\/jkms.2008.23.2.185","article-title":". The spectrum of Epstein-Barr virus-associated lymphoproliferative disease in Korea: incidence of disease entities by age groups.","volume":"23","author":"Cho","year":"2008","journal-title":"J Korean Med Sci"},{"key":"R3-21-20210202","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/rmv.505","article-title":"Pathogenesis of chronic active Epstein-Barr virus infection: is this an infectious disease, lymphoproliferative disorder, or immunodeficiency.","volume":"16","author":"Kimura","year":"2006","journal-title":"Rev Med Virol"},{"key":"R4-21-20210202","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1440-1827.2008.02213.x","article-title":". Proposed categorization of pathological states of EBV-associated Tnatural killer-cell lymphoproliferative disorder (LPD) in children and young adults: overlap with chronic active EBV infection and infantile fulminant EBV T-LPD.","volume":"58","author":"Ohshima","year":"2008","journal-title":"Pathol Int"},{"key":"R5-21-20210202","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1002\/ajh.21247","article-title":". Allogeneic hematopoietic stem cell transplantation for Epstein-Barr virus-associated Tnatural killer-cell lymphoproliferative disease in Japan.","volume":"83","author":"Sato","year":"2008","journal-title":"Am J Hematol"},{"key":"R7-21-20210202","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2165\/00128071-200809050-00003","article-title":". Mucocutaneous manifestations of Epstein-Barr virus infection.","volume":"9","author":"Mendoza","year":"2008","journal-title":"Am J Clin Dermatol"},{"key":"R8-21-20210202","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0037-1963(03)70004-3","article-title":"Epstein-Barr virus-associated T-natural killer cell lymphoproliferative diseases.","volume":"40","author":"Yachie","year":"2003","journal-title":"Semin Hematol"},{"key":"R9-21-20210202","first-page":"1165","article-title":". Clinicopathological states of Epstein-Barr virus-associated TNK-cell lymphoproliferative disorders (severe chronic active EBV infection) of children and young adults.","volume":"24","author":"Suzuki","year":"2004","journal-title":"Int J Oncol"},{"key":"R10-21-20210202","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0190-9622(99)70210-0","article-title":". Atypical hydroa vacciniforme in childhood: from a smoldering stage to Epstein-Barr virus-associated lymphoid malignancy.","volume":"40","author":"Iwatsuki","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"R11-21-20210202","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/ajh.20659","article-title":". NK-cell repertoire is feasible for diagnosing Epstein-Barr virus-infected NK-cell lymphoproliferative disease and evaluating the treatment effect.","volume":"81","author":"Sawada","year":"2006","journal-title":"Am J Hematol"},{"key":"R12-21-20210202","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S0190-9622(00)90127-0","article-title":"Hydroa vacciniforme: a clinical and follow-up study of 17 cases.","volume":"42","author":"Gupta","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"R13-21-20210202","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1001\/archderm.1982.01650200056017","article-title":". Hydroa vacciniforme: diagnosis and therapy.","volume":"118","author":"Goldgeier","year":"1982","journal-title":"Arch Dermatol"},{"key":"R14-21-20210202","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/j.1365-2133.1996.tb06994.x","article-title":". An Epstein-Barr virus-associated lymphoproliferative lesion of the skin presenting as recurrent necrotic papulovesicles of the face.","volume":"134","author":"Cho","year":"1996","journal-title":"Br J Dermatol"},{"key":"R15-21-20210202","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1001\/archderm.142.5.587","article-title":". Pathogenic link between hydroa vacciniforme and Epstein-Barr virus-associated hematologic disorders.","volume":"142","author":"Iwatsuki","year":"2006","journal-title":"Arch Dermatol"},{"key":"R16-21-20210202","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1111\/j.1365-4632.2007.03102.x","article-title":". Hydroa vacciniforme-like Epstein-Barr virus-associated monoclonal T-lymphoproliferative disorder in a child.","volume":"46","author":"Wu","year":"2007","journal-title":"Int J Dermatol"},{"key":"R17-21-20210202","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/j.1365-2133.2004.06038.x","article-title":". Epstein-Barr virus-associated lymphoproliferative lesions presenting as a hydroa vacciniforme-like eruption: an analysis of six cases.","volume":"151","author":"Cho","year":"2004","journal-title":"Br J Dermatol"},{"key":"R18-21-20210202","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/j.1600-0560.2007.00836.x","article-title":". Hydroa-like lymphoma with CD56 expression.","volume":"35","author":"Doeden","year":"2008","journal-title":"J Cutan Pathol"},{"key":"R19-21-20210202","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/00129039-200203000-00002","article-title":". Hydroa-like cutaneous T-cell lymphoma: a clinicopathologic and molecular genetic study of 16 pediatric cases from Peru.","volume":"10","author":"Barrionuevo","year":"2002","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"R20-21-20210202","first-page":"364","article-title":"Hydroa vacciniforme-like primary cutaneous CD8-positive T-cell lymphoma.","volume":"18","author":"Feng","year":"2008","journal-title":"Eur J Dermatol"},{"key":"R21-21-20210202","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1046\/j.1365-2230.2001.00805.x","article-title":". Epstein-Barr virus-associated peripheral T-cell lymphoma in adults with hydroa vacciniforme-like lesions.","volume":"26","author":"Cho","year":"2001","journal-title":"Clin Exp Dermatol"},{"key":"R22-21-20210202","first-page":"207","article-title":"Abdominal complications of infectious mononucleosis.","volume":"1","author":"Robinson","year":"1988","journal-title":"J Am Board Fam Pract"},{"key":"R23-21-20210202","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1177\/08830738060210051101","article-title":". Pediatric Epstein-Barr virus-associated encephalitis: 10-year review.","volume":"21","author":"Doja","year":"2006","journal-title":"J Child Neurol"},{"key":"R24-21-20210202","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1177\/088307380001501204","article-title":". Persistent preceding focal neurologic deficits in children with chronic Epstein-Barr virus encephalitis.","volume":"15","author":"Caruso","year":"2000","journal-title":"J Child Neurol"},{"key":"R25-21-20210202","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.ejim.2006.09.024","article-title":"Acute hemolytic anemia following infectious mononucleosis.","volume":"18","author":"Garefalakis","year":"2007","journal-title":"Eur J Intern Med"},{"issue":"Suppl 3","key":"R26-21-20210202","first-page":"657","article-title":"Hypersensitivity to mosquito bites and hydroa vacciniforme.","volume":"64","author":"Iwatsuki","year":"2006","journal-title":"Nippon Rinsho"},{"key":"R27-21-20210202","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1182\/blood-2005-01-0377","article-title":". Efficacy and safety of rituximab in B-cell post-transplantation lymphoproliferative disorders: results of a prospective multicenter phase 2 study.","volume":"107","author":"Choquet","year":"2006","journal-title":"Blood"},{"key":"R28-21-20210202","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1182\/blood-2004-07-2965","article-title":". Treatment of primary Epstein-Barr virus infection in patients with X-linked lymphoproliferative disease using B-cell-directed therapy.","volume":"105","author":"Milone","year":"2005","journal-title":"Blood"},{"key":"R29-21-20210202","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1182\/blood-2006-12-063008","article-title":". Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial.","volume":"110","author":"Haque","year":"2007","journal-title":"Blood"},{"key":"R30-21-20210202","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/S0140-6736(02)09672-1","article-title":". Treatment of Epstein-Barr-virus-positive post-transplantation lymphoproliferative disease with partly HLA-matched allogeneic cytotoxic T cells.","volume":"360","author":"Haque","year":"2002","journal-title":"Lancet"}],"container-title":["The American Journal of Dermatopathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00000372-201212000-00021","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,31]],"date-time":"2022-01-31T18:01:06Z","timestamp":1643652066000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000372-201212000-00021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":29,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/dad.0b013e3181c036de","relation":{},"ISSN":["0193-1091"],"issn-type":[{"value":"0193-1091","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}